Blog

Antikörperwahl: Vier Prioritäten für labornahe Durchflusszytometrie Wählen Sie Antikörper für Ihre Durchflusszytometrie anhand von vier Prioritäten: validiertes Zielantigen mit passendem Klon, ein Fluorochrom, das zu Expressionsstärke und Panel-Design passt, eine dokumentierte Titration und saubere Kontrollen für Kompensation und Hintergrund. Alles andere, Marke, Preis, Verpackungsgröße, ist zweitrangig. Die folgenden Abschnitte zeigen Ihnen, wie Sie jeden dieser vier Punkte im Labor konkret umsetzen, von der Herstellerdatenbewertung bis zum fertigen Panel. Kurz gesagt: Die Auswahl der Antikörper sollte sich an validierten Zielantigenen, passenden Fluorochromen, dokumentierten Titratione …

4 étapes pour des comptes rendus ELISA défendables en laboratoire Un compte rendu ELISA exploitable réunit l’objectif de l’essai, la référence et le lot du kit, la méthode suivie, les densités optiques brutes, le modèle d’ajustement retenu (4PL ou 5PL) et les facteurs de dilution appliqués. Chaque décision critique, la gestion du blanc, les puits exclus, les extrapolations, doit être annotée directement dans le rapport plutôt que gardée en mémoire. Quand un point de méthode reste flou, l’assistance technique d’Assay Genie permet de trancher avant publication plutôt qu’après. En bref: La gestion rigoureuse des blancs, des puits aberrants et des extrapolations doit être documentée précisém …

Investigadores: ahorre días de ensayo con PBS y TBS según la técnica Para western blot con detección de fosforilación, use TBS o TBS-T: el fosfato de PBS puede interferir con anticuerpos anti-fosfo y con fosfatasa alcalina. Para lavados isotónicos, ELISA y cultivo celular, PBS sigue siendo el estándar, con o sin Ca2+/Mg2+ según necesite disociar células o mantenerlas adheridas. La diferencia real está en el tampón químico: fosfato frente a Tris, y en cómo cada uno interactúa con sus enzimas y anticuerpos. En resumen: El fosfato en PBS puede interferir en detectores fosfo-específicos y enzimáticos, por eso se prefiere TBS en experimentos con fosfoproteínas. TBS tiene un pKa más alto y sen …

.agblog{--ag:#1a4fd6;--agl:#eef3ff;--bd:#e3e8f0;--tx:#1f2733;--mut:#5a6779;color:var(--tx);font-size:17px;line-height:1.75} .agblog h2{font-size:1.5rem;line-height:1.3;margin:2.2em 0 .6em;padding-bottom:.3em;border-bottom:2px solid var(--bd);font-weight:700} .agblog h3{font-size:1.15rem;margin:1.7em 0 .5em;font-weight:700} .agblog p{margin:0 0 1.15em} .agblog img{max-width:100%;height:auto;border-radius:10px;display:block;margin:1.7em auto} .agblog ul,.agblog ol{margin:0 0 1.25em;padding-left:1.35em} .agblog li{margin:0 0 .55em} .agblog a{color:var(--ag);text-decoration:underline;text-underline-offset:2px} .agblog a:hover{text-decoration:none} .agblog table{width:100%;border-collapse:collap …

.agblog{--ag:#1a4fd6;--agl:#eef3ff;--bd:#e3e8f0;--tx:#1f2733;--mut:#5a6779;color:var(--tx);font-size:17px;line-height:1.75} .agblog h2{font-size:1.5rem;line-height:1.3;margin:2.2em 0 .6em;padding-bottom:.3em;border-bottom:2px solid var(--bd);font-weight:700} .agblog h3{font-size:1.15rem;margin:1.7em 0 .5em;font-weight:700} .agblog p{margin:0 0 1.15em} .agblog img{max-width:100%;height:auto;border-radius:10px;display:block;margin:1.7em auto} .agblog ul,.agblog ol{margin:0 0 1.25em;padding-left:1.35em} .agblog li{margin:0 0 .55em} .agblog a{color:var(--ag);text-decoration:underline;text-underline-offset:2px} .agblog a:hover{text-decoration:none} .agblog table{width:100%;border-collapse:collap …

.agblog{--ag:#1a4fd6;--agl:#eef3ff;--bd:#e3e8f0;--tx:#1f2733;--mut:#5a6779;color:var(--tx);font-size:17px;line-height:1.75} .agblog h2{font-size:1.5rem;line-height:1.3;margin:2.2em 0 .6em;padding-bottom:.3em;border-bottom:2px solid var(--bd);font-weight:700} .agblog h3{font-size:1.15rem;margin:1.7em 0 .5em;font-weight:700} .agblog p{margin:0 0 1.15em} .agblog img{max-width:100%;height:auto;border-radius:10px;display:block;margin:1.7em auto} .agblog ul,.agblog ol{margin:0 0 1.25em;padding-left:1.35em} .agblog li{margin:0 0 .55em} .agblog a{color:var(--ag);text-decoration:underline;text-underline-offset:2px} .agblog a:hover{text-decoration:none} .agblog table{width:100%;border-collapse:collap …

Utilisez une coloration protéine totale, comme le Ponceau S, quand vos traitements risquent de faire varier l’expression des protéines de ménage. Sinon, une protéine housekeeping validée pour votre échantillon reste suffisante. Dans tous les cas, ajoutez des contrôles positifs et négatifs documentés, et vérifiez que l’anticorps a été validé pour l’application exacte que vous testez, qu’il s’agisse d’un western blot ou d’un test ELISA. En bref: La coloration protéine totale comme le Ponceau S est recommandée si les traitements modifient l’expression de protéines de référence, sinon une protéine housekeeping validée suffit. Les contrôles doivent inclure des lysats positifs, négatifs ou …

Para recuperar la actividad biológica de proteínas recombinantes expresadas como cuerpos de inclusión, la vía más fiable combina una solubilización controlada con un replegamiento gradual, mediante dilución, diálisis o cromatografía asistida por chaperonas según la proteína. El éxito depende de controlar pH, potencial redox y concentración desde el primer paso. Los protocolos, las variables críticas y los controles analíticos que confirman un plegamiento correcto se detallan a continuación. En resumen: La elección del método de renaturalización depende del tamaño, número de puentes disulfuro y volumen disponible, siendo la cromatografía asistida por chaperonas más eficiente para lotes …

Der richtige Startpunkt für die meisten ELISA‑Protokolle ist Magermilchpulver (NFDM) in TBST für HRP‑basierte Assays ohne Phospho‑Ziele, typischerweise in der gängigen Konzentrationsspanne. Bei Streptavidin‑Biotin‑Systemen oder Phospho‑Antikörpern greifen Sie stattdessen zu biotinfreiem BSA in Konzentrationen, die häufig üblich sind. Die entscheidende Regel dahinter: Der Blocker wird nach der Detektionschemie gewählt, nicht nach Gewohnheit. Rezepte, Puffer und Fehlerbehebung folgen weiter unten. Kurz gesagt: Milchpulver ist günstig und für Standard-HRP-Assays geeignet, kann aber bei Phospho‑Antikörpern oder Biotin‑Nachweisen unerwünschte Interferenzen verursachen. BSA in biotinfreier …

Quick answer A researcher's samples read negative at the standard 1-hour incubation on the MycoGenie Rapid Mycoplasma Detection Kit (MORV0011), but many turned positive after 2 hours. This is not a false positive. The cultures were sub-confluent (~40%), so the low mycoplasma biomass kept a genuine, low-level infection below the colour-change threshold at 60 minutes. Anchoring the run with the kit's positive and negative controls and extending incubation modestly (~90 minutes) confirmed the true positives. On this page The problem Snapshot of the data Why it happens Our analysis What we recommended FAQ …

You can remove almost every B cell from an animal and barely move its antibody titre. That is not a failed experiment — it is the expected result, and it follows from one fact: CD20 is switched off as a B cell becomes a plasma cell. Anti-CD20 clears the recirculating pool and leaves the long-lived plasma cell, which has no CD20 to bind, sitting in its bone-marrow niche secreting the pathogenic antibody exactly as before. Depleting B cells and depleting antibody are two different experiments, and conflating them is the most common mistake in this field. B-CELL LINEAGE — WHAT A DEPLETING ANTIBODY CAN SEET-CELL AND CYTOKINE HELPB-CELL SURFACE — SURVIVAL RECEPTORSNON-CANONICAL NF-κB — SUR …

Two drugs aimed at the same axis can give opposite results in the same disease. Blocking IL-23p19 is highly effective in psoriasis and works in Crohn’s disease. Blocking IL-17A directly is highly effective in psoriasis and made Crohn’s disease worse in trial. Both agents hit the same pathway. The reason they diverge is that Th17 cells are not one population doing one job — they are a spectrum, and IL-23 is the cytokine that decides where on that spectrum a cell sits. This is the most consequential thing to understand about the axis, and it is invisible if you treat “Th17” as a single lineage. DENDRITIC CELL — THE POLARISING CYTOKINE MILIEUNAÏVE CD4+ T CELL — SU …

Elige ELISA cuando necesites cuantificar una proteína con precisión, procesar muchas muestras o trabajar con volúmenes pequeños; elige Western blot cuando necesites confirmar el tamaño molecular, distinguir isoformas o verificar la especificidad de una señal. En la práctica, muchos laboratorios usan ELISA para el cribado inicial y reservan el Western blot como confirmación cuando el resultado exige certeza estructural. En resumen: El ELISA es más adecuado para cuantificar proteínas en múltiples muestras y volúmenes pequeños, mientras que el Western blot se usa para confirmar la identidad y tamaño molecular de la proteína. El ELISA en placa permite automatización y procesamiento en par …

Le protocole ELISA sandwich standard suit six étapes: revêtement du puits avec l’anticorps de capture, blocage, incubation des standards et échantillons, ajout de l’anticorps de détection, puis du conjugué reporter, et enfin développement et lecture. Trois contrôles conditionnent la validité du résultat: une courbe standard, un blanc et un contrôle positif. Titrer les anticorps en amont et travailler en duplicata ou triplicata reste non négociable. En bref: La préparation correcte des standards, en cascade et avec la bonne matrice, est essentielle pour obtenir des résultats précis et reproductibles. La titration rigoureuse des couples d’anticorps de capture et de détection, en checker …

Ein kompetitiver ELISA misst Analytkonzentrationen über ein invertiertes Signal: Probeantigen und ein markierter Tracer konkurrieren um dieselben, begrenzten Bindungsstellen. Je mehr Analyt in der Probe steckt, desto weniger Tracer bindet, desto schwächer das Messsignal. Dieses Format bewährt sich vor allem bei kleinen Molekülen mit nur einem Epitop, etwa Hormonen oder Toxinen, wo ein Sandwich-ELISA schlicht keinen zweiten Bindungspartner findet. Ohne saubere Validierung bleibt jede Kurve aber Makulatur. Kurz gesagt: Bei kleinen Molekülen wie Hormonen oder Toxinen ist das kompetitive ELISA die einzige zuverlässige Methode, da kein zweites Bindungs-Epitop notwendig ist. Die korrekte Re …

QUICK ANSWER A researcher ran a panel of EMT-marker ELISA kits (E-cadherin, claudin-1, N-cadherin, vimentin, ZEB1, TWIST1) on breast cell-line lysates and found E-cadherin reading "positive" in a mesenchymal line where it is barely expected — an apparent false positive. The kits were fine. The mismatch came from comparing raw lysate concentrations across cell lines without normalizing to total protein, plus a detergent-heavy lysis buffer the assays are not validated for. Normalize each result to total protein (analyte per mg protein), use a compatible buffer, and the expected epithelial-vs-mesenchymal pattern returns. On this page The problem …

For reproducible, isoform-specific detection, choose a monoclonal antibody; for robust detection across multiple epitopes or faster turnaround, choose a polyclonal antibody. The real tradeoff is epitope dependency and cost against supply variability and lot consistency. Most researchers end up needing both classes at different stages of a project, not one winner across the board. TL;DR: Monoclonal antibodies are more suitable for long-term, reproducible studies due to their lot-to-lot consistency and high purity. Polyclonal antibodies offer broader epitope recognition and faster, cheaper production but suffer from batch variability and limited supply. The choice depends on assay type, sa …

A T cell does not choose which tissue to defend. The tissue chose it, during priming. A naive T cell has no tropism at all; it acquires one from the dendritic cell that activates it, and the instruction is written into which adhesion and chemokine receptors it puts on its surface. For the intestine that instruction is retinoic acid, and it produces one of the cleanest examples of tissue-specific immunity in mammalian biology — clean enough that it has yielded a gut-selective drug class. GUT-DRAINING LYMPH NODE — IMPRINTINGGUT ADDRESSOTHER ROUTESINTESTINAL ENDOTHELIUM AND EPITHELIUMEGRESS SWITCHED OFFTRM PROGRAMMEBARRIER AND EFFECTOR OUTPUTimprintingperipheral-node homing, switched off …

The most abundant immunosuppressive molecule in a solid tumour is not a protein. It is adenosine — a metabolite, produced from ATP in two enzymatic steps, at concentrations orders of magnitude above those found in healthy tissue. It is not secreted by a specialised cell type, it cannot be knocked out, and it acts on every immune cell that carries a receptor for it. Understanding how a danger signal becomes its own antidote is the most useful thing you can know about the tumour microenvironment that checkpoint biology does not tell you. HYPOXIC, DYING TISSUE — ATP IS RELEASED AS A DANGER SIGNALCELL SURFACE — ECTONUCLEOTIDASEScAMP → PKA — THE SUPPRESSIVE SIGNALSUPPRESSED CYTOTOXICITYSEL …

QUICK ANSWER On a Human I-FABP/FABP2 ColorStep ELISA, the top of the standard curve looked perfect while the three lowest standards showed duplicate %CVs of 37–450% — because their optical density (OD) sat right at the blank. Near the bottom of the working range, a few milli-OD of well-to-well noise becomes a huge relative error, and dual-wavelength (OD450–620) subtraction pushed near-zero wells negative. The fix: keep the curve inside the validated 0.156–10 ng/mL range, retain single-wavelength OD450, and bring low samples up into the reliable mid-curve (run neat or concentrate). QC confirmed no kit defect. On this page The pro …

An antibody's variable domains decide what it binds. Its Fc decides what happens next — and that is not a detail of formulation, it is half the mechanism. Which Fcγ receptor the constant region engages determines whether an opsonised cell is killed by an NK cell, eaten by a macrophage, lysed by complement, or simply ignored. It also determines whether your isotype control is a control at all. This article walks the Fcγ receptor family, the single kinase cascade they share, the one inhibitory receptor that subtracts from all of it, and the three effector mechanisms they feed — plus FcRn, which does none of the above and yet sets the half-life of the whole molecule. Ke …

Both interferon families run through STAT1, and that single shared subunit is why they are so often conflated — and why conflating them is a mistake. Type I interferon assembles STAT1 into a three-part complex with STAT2 and IRF9 that reads one class of promoter element. Type II interferon assembles STAT1 into a homodimer that reads a different one. Same phospho-STAT1 band on a blot; two largely non-overlapping gene programmes; two different reasons to block them. This article walks both arms from induction to output, and ends with the part that matters commercially: the fact that the interferon a successful T-cell response produces is also the signal that installs the brake …

Transplant rejection is the fastest, most violent adaptive immune response a body can mount — and it is a response to a molecule rather than to a pathogen. Somewhere between one and ten per cent of a recipient’s naive T-cell repertoire will react to a mismatched MHC molecule, which is orders of magnitude above the frequency for a conventional antigen. That single number explains why an untreated allograft fails in days, why the immunology of transplantation has its own vocabulary, and why the antibody toolkit for studying it is unusually deep. This article walks the pathway from the mismatched MHC molecule itself through the three recognition routes, the synapse they share, the …

PD-1 gets the attention, but it is one brake among many — and the others do not work the same way. The co-inhibitory receptors are routinely drawn as interchangeable stop signs on a T cell. They are nothing of the kind. They read different ligands, engage different intracellular machinery, and in one case do not signal into the T cell at all so much as strip the antigen-presenting cell of the molecules it needs to stimulate. Understanding which mechanism each receptor uses is the difference between a rational combination and a hopeful one. Key takeaways CTLA-4 does not merely outcompete CD28 — it removes CD80 and CD86 from the antigen-presenting cell by trans-endocytosis, making …